Venmax Drugs & Pharmaceuticals Share Price

BSE
26
-0.39 (0.00%)
VENMAX • 28 May, 2025 | 03:09 PM
BUY
The current prices are delayed, login or Open Demat Account for live prices.
Venmax Drugs & Pharmaceuticals Stock Performance
Today’s Low - High
26.00
27.59
26.00
27.59
52 Week Low - High
6.27
30.88
6.27
30.88

Open

27.59

Prev. Close

26.39

Volume

4,600.00

Total Traded Value

1.20 L

View details of Market Depth
Venmax Drugs & Pharmaceuticals Fundamental

Market Cap (in crs)

13.83

Face Value

10

Turnover (in lacs)

1.20

Key Metrics
Qtr Change %
314.67% Gain from 52W Low
27.3
Dividend yield 1yr %
0

Venmax Drugs & Pharmaceuticals shareholding Pattern

Promoter
23.1%
Domestic Institutions
0.2%
Public
76.7%
Promoter
23.1%
Domestic Institutions
0.2%
Public
76.7%
Promoter
23.1%
Domestic Institutions
0.2%
Public
76.7%
Promoter
23.1%
Domestic Institutions
0.2%
Public
76.7%
Promoter
23.1%
Domestic Institutions
0.2%
Public
76.7%
Promoter
23.1%
Domestic Institutions
0.2%
Public
76.7%

Venmax Drugs & Pharmaceuticals Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
26
Current Price
Bullish Moving Averages
5
Bearish Moving Averages
11
5Day EMA
27.00
10Day EMA
27.10
12Day EMA
27.10
20Day EMA
27.20
26Day EMA
27.10
50Day EMA
26.50
100Day EMA
23.60
200Day EMA
18.30
5Day SMA
27.00
10Day SMA
27.10
20Day SMA
27.30
30Day SMA
27.20
50Day SMA
27.10
100Day SMA
25.70
150Day SMA
19.30
200Day SMA
15.10
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
4274 Rs
4274 Rs
Week Rs
8173 Rs
8173 Rs
Month Rs
9792 Rs
9792 Rs
Resistance & Support
26.54
Pivot
Resistance
First Resistance
27.15
Second Resistance
27.90
Third Resistance
28.51
Support
First Support
25.79
Second support
25.18
Third Support
24.43
Relative Strength Index
45.96
Money Flow Index
30.41
MACD
-0.03
MACD Signal
0.05
Average True Range
1.64
Average Directional Index
21.01
Rate of Change (21)
-0.42
Rate of Change (125)
543.66

Venmax Drugs & Pharmaceuticals Latest News

10 MAY 2025 | Saturday

Venmax Drugs and Pharmaceuticals Ltd - 531015 - Announcement under Regulation 30 (LODR)-Newspaper Publication

09 MAY 2025 | Friday

Venmax Drugs and Pharmaceuticals Ltd - 531015 - Integrated Filing (Financial)

09 MAY 2025 | Friday

Venmax Drugs and Pharmaceuticals Ltd - 531015 - Audited Financial Results March 31St 2025.

View More

Venmax Drugs & Pharmaceuticals Company background

Founded in: 1988
Managing director: N Krishnaniah
Venmax Drugs Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Limited Company under the name and style of Yenkay Medico Private Limited, on 28 September, 1998. The Company thereafter changed its name to Yenkey Drugs Pharmaceuticals Private Limited on 18 January, 1995. It became a Public Limited Company on February 3, 1995 with Yenkey Drugs Pharmaceuticals Limited. Finally, the Company changed its name to Venmax Drugs Pharmaceuticals Limited on April 13, 2009. For the past six months, Company focused on establishing chain of Medical Stores with a brand name as Ananya Pharma under the Venmax Drugs Pharma Limited, with the backing support of Formulations plant (Suzichem Labs). Initially, the Company engaged in the business of pharmaceutical products, drug intermediaries APIs etc. The Company is engaged in the business of IT ITES services.
Read More

Venmax Drugs & Pharmaceuticals FAQs

You can easily buy Venmax Drugs & Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Venmax Drugs & Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -